Price

rebased to 0%

GSK, solidBMY, dashed

GSKGSK plc

51.26−0.55%

Mkt cap$111.2BRevenue—Revenue—

BMYBristol Myers Squibb Co

62.63+0.79%

Regular sessionNov 10 '26

Mkt cap$127.0BRevenue$13.1BQ3 FY26Revenue$48.2BFY25

vs

Compare

Regular sessionNov 10 '26

GSKGSK plc

vs

BMYBristol Myers Squibb Co

51.26−0.55%

Price

62.63+0.79%

$111.2B

Mkt cap

$127.0B

—

Revenue

$13.1BQ3 FY26

—

Revenue

$48.2BFY25

GSK compared with BMY: revenue, margins and what each company keeps, and the suppliers and customers both name